Literature DB >> 24975835

The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.

Tao Sun1, Mingqi Chen1, Xiaoyan Lin2, Ruixiang Yu1, Yong Zhao1, Jianhang Wang3.   

Abstract

Previous studies suggest that the osteoprotegerin gene (OPG) plays an important role in the development of osteoporosis. This study aims to investigate the potential association between OPG genetic polymorphisms and bone mineral density (BMD) and osteoporosis in postmenopausal women. 938 Chinese postmenopausal women were enrolled. The lumbar spine (L(2-4)) BMD, neck BMD, and total hip BMD were measured by dual energy X-ray absorptiometry (DEXA). The genotypes of OPG genetic polymorphisms were evaluated by the created restriction site-polymerase chain reaction (CRS-PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and DNA sequencing methods. Our data indicated that subjects with genotype TT of the g.26395T>C genetic polymorphism showed a significantly higher adjusted value of BMD when compared with those of genotypes TC and CC. Subjects with genotype AA of the g.27649A>G genetic polymorphism showed a significantly higher adjusted value of BMD than those of genotypes AG and GG. These findings suggest that the OPG genetic polymorphisms may affect BMD and osteoporosis in Chinese postmenopausal women.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Genetic polymorphisms; Osteoporosis; Osteoprotegerin gene; Postmenopausal women

Mesh:

Substances:

Year:  2014        PMID: 24975835     DOI: 10.1016/j.intimp.2014.06.023

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  Polymorphisms in key bone modulator cytokines genes influence bisphosphonates therapy in postmenopausal women.

Authors:  C A D Lima; N R Javorski; A P O Souza; A D Barbosa; A P M C Valença; S Crovella; P R E Souza; J De Azevedo Silva; P Sandrin-Garcia
Journal:  Inflammopharmacology       Date:  2017-02-21       Impact factor: 4.473

2.  Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.

Authors:  Shouyi Li; Huiqiang Jiang; Ningke Du
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

3.  OPG rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration.

Authors:  Jing-Bo Xue; Xin-Li Zhan; Wen-Jun Wang; Yi-Guo Yan; Chong Liu
Journal:  Exp Ther Med       Date:  2016-05-16       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.